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Introduction  
Atherosclerosis increasingly threatens human health worldwide. It is a chronic 
inflammatory disease, which involves the formation of atherosclerotic plaques in the arteries 
that are characterized by inflammation, lipid accumulation, cell death and fibrosis [1]. Rupture 
of a plaque, which induces sudden thrombotic occlusion of the artery at the site of disruption, 
can cause myocardial infarction and heart failure. It can result in ischaemic stroke and transient 
ischaemic attack in the arteries that perfuse the brain. Atherosclerosis can also lead to 
hypertension, abdominal aortic aneurysms, critical limb ischaemia and renal impairment. 
Therefore, understanding of the entire mechanism of atherosclerosis; initiation, progression, 
complications and regression is crucial for prevention and clinical treatment.  
“Response-to-injury hypothesis” is a general model for explain the mechanism of 
atherogenesis suggested by Ross and colleagues [2, 3]. In the hypothesis, endothelial cells in the 
arteries are activated by various factors such as hyperlipidaemia, hypertension or smoking. Then, 
accumulation of foam cells and immune cells in the intima occurs during the early stage of 
plaque formation; circulating monocytes and T-lymphocytes bind to the activated endothelium 
and enter the arterial intima. Monocytes differentiate into macrophages in response to local 
stimuli. Atherogenic lipoprotein particles are taken up by macrophages, which leads to 
intracellular cholesterol accumulation and the formation of foam cells. On the other hand, 
vascular smooth muscle cells (SMCs) are one of the main components of mature plaques. In 
response to atherogenic stimuli such as growth factors or cytokines secreted by activated 
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endothelial cells or macrophages, SMCs migrate from media to intima, proliferate and 
accumulate cholesteryl esters.  
SMCs retain remarkable plasticity, and they can undergo relatively rapid and reversible 
phenotypic changes in response to local environmental signals. SMCs have two phenotypes. 
One phenotype is the contractile-type SMC which exists in normal artery. Contractile-type 
SMCs function is contraction and these SMCs do not proliferate. The other phenotype is the 
synthetic (dedifferentiated)–type SMC. The synthetic–type SMC can be observed in 
atherosclerotic lesions. Synthetic–type SMCs proliferate and lose the ability to contract after 
dedifferentiation [4]. Although phenotypic change in SMCs is a crucial event for the progression 
or regression of atherosclerosis, and that inhibition of excessive proliferation and maintenance 
of the differentiated state are important for the prevention and treatment of vascular diseases, 
the mechanism of SMC phenotypic change is not fully understood. Research of SMC phenotype 
is difficult because it is not possible to maintain SMCs for an extended time in the differentiated 
state; if SMCs are isolated from the extracellular matrix (ECM) and cultured in medium 
containing 5% serum, they transform to the dedifferentiated phenotype [5].  
We previously reported that dedifferentiated rabbit SMCs displayed similar features to 
those observed in aortic SMCs when cultured in three-dimensional matrices of type-I collagen 
called “honeycombs” [6]. The SMCs stopped proliferating despite the presence of sufficient 
serum in the medium, showed morphological changes, and expressed caldesmon heavy chain (a 
marker of mature differentiated SMCs). We propose that SMC cultured in honeycomb is a good 
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model for the contractile-type SMC, and that this culture system is useful for studying 
phenotype changes in SMCs. One of the purposes of this study is to clarify the mechanisms of 
proliferative inhibition and induction of contraction of SMCs cultured in honeycombs. 
Specifically, we focus on the function of eukaryotic initiation factors on proliferative inhibition, 
and that of filamin on induction of contraction.  
Research for prevention and clinical treatment of atherosclerosis is quite important as 
well as understanding of the cellular biology involved in atherosclerosis. In line with this 
concept, we focus on components of food for preventing atherogenesis. Kefiran is the 
exopolysaccharide produced by Lactobacillus kefiranofacien, and has been proposed to have 
many health promoting properties [7]. Kefiran is expected to ameliorate atherogenesis because it 
has hypocholesterolemic [8, 9], hypotensive [10, 11] and anti-inflammatory effects [12]. When 
rabbits were fed a high-cholesterol diet for 8–12 weeks, levels of beta-very-low-density 
lipoprotein (-VLDL) were elevated and a large area of atherosclerotic lesions developed. Thus, 
the second purpose of this study is to investigate the antiatherogenic effect of kefiran in rabbits 
fed a high-cholesterol atherogenic diet. 
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Chapter 1   
Relationship between eukaryotic initiation factors and proliferative arrest of vascular 
smooth muscle cells cultured in type-I collagen matrix honeycombs  
 
SMCs undergo phenotypic changes upon differentiation and dedifferentiation. A shift 
from a dedifferentiated to a differentiated phenotype is a crucial event in the regression of 
atherosclerosis [13, 14]. In normal aortas, SMCs can contract when they differentiate, but in 
atherosclerotic lesions, SMCs undergo proliferation and lose the ability to contract after 
dedifferentiation [4]. SMCs in the normal arterial media are surrounded by components of the 
ECM, which is thought to maintain SMCs in the differentiated phenotype. If SMCs are isolated 
from the ECM and cultured in medium containing 5% serum, they transform to the 
dedifferentiated phenotype [5].  
Dedifferentiated rabbit SMCs displayed unique features that are similar to those 
observed in aortic SMCs when cultured in three-dimensional matrices of type-I collagen called 
“honeycombs” [6]. The SMCs stopped proliferating despite the presence of sufficient serum in 
the medium, which enables to culture them in honeycombs for an extended time. However, the 
mechanisms of proliferative inhibition are unknown.  
Protein synthesis is one of the important step for cell growth. Translation initiation in 
eukaryotes is regulated by interactions of eukaryotic initiation factors (eIFs) and RNA 
molecules [15]. A complex of eIF2 (consists of eIF2,  and ) binds to Met-tRNAi in a GTP 
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depending manner, and then associates with 40S ribosomal subunit with eIF3 to form 43S 
preinitiation complex. Recruitment of this complex to the 5’ cap structure of mRNA is mediated 
by the trimeric eIF4F complex, which consists of eIF4A (an RNA helicase), eIF4E (the cap 
binding protein) and eIF4G (a large scaffolding protein), together with eIF4B (a 
helicase-stimulatory factor). The 40S ribosomal subunit with eIFs scans the 5’ untranslated 
region (5’-UTR) of the mRNA until it encounters a start codon, followed by joining of 60S 
ribosomal subunit and hydrolysis of the GTP, which allows the beginning of polypeptide 
synthesis. Although treatment of rapamycin which influences on mTOR/p70 S6K1 pathway 
inhibits protein synthesis and proliferation of SMCs [16, 17], the relationship between 
proliferation of SMCs and regulation of eIFs is not well understood.  
Polyamines (putrescine, spermidine and spermine) are essential for cell growth [18]. 
Polyamines mostly exist as polyamine-RNA complex in Escherichia coli and stimulate the 
synthesis of specific proteins which are important for cell growth at translational level. In 
mammalian cells, the most polyamines also exist as polyamine-RNA complex. Recently, it has 
been reported that syntheses of certain proteins were preferentially enhanced by polyamines at 
the level of translation in mammalian cells [19]. We previously reported that protein synthesis in 
rabbit SMCs cultured in honeycombs was reduced compared to that in SMCs on plates, and 
polyamine contents in rabbit SMCs cultured in honeycombs were lower than those in SMCs on 
plates [6, 20]. From these things, it is assumed that regulation of translation initiation is 
important for growth of SMCs in honeycombs and that polyamines influence on translation 
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initiation via regulation of eIFs. In this study, we focus on regulation of eIFs in human aortic 
SMCs cultured in honeycombs. 
 
 
Materials and Methods 
Honeycomb collagen tubes 
Collagen sponges called honeycombs that consisted of type-I collagen were obtained 
from Koken Co. Ltd. (Japan). The structure of the honeycomb was porous and consisted of 
many tubes aligned side-by-side, similar to a beehive [6]. The pore diameters of the tubes were 
200–300 m. The honeycombs were cut vertically into cubes of dimensions 5 × 5 × 2 mm. 
 
Cell culture 
Human aortic SMCs (Lonza) were cultured under standard cell culture conditions 
(37°C, 5% CO2) in smooth muscle cell basal medium (SmBM, Lonza) supplemented with 
human recombinant fibroblast growth factor-B (hFGF-B), human recombinant epidermal 
growth factor (hEGF), insulin, gentamicin/amphotericin B (GA) and 2% fetal bovine serum 
(FBS), as suggested by the supplier. Two lots of SMCs were used for the experiments; each lot 
was derived from a 20 and a 36 year-old man. The lots were described as hSMC1 (lot NO. 
7F4322) and hSMC2 (lot NO. 6F4364), respectively. hSMC1 was used for Fig. 1, 2B and 2C. 
hSMC2 was used for another experiment. When cells reached 90% confluence, hSMCs were 
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treated with trypsin–EDTA (Sigma–Aldrich) for 1–2 minutes, and released hSMCs were 
subcultured on dishes (diameter, 10 cm) in 10 ml of medium. hSMCs were subcultured every 
2–4 days, and the process was repeated. hSMCs used in this study were passages 7-9. 
Animal experiments were carried out according to the “Principles of Laboratory 
Animal Care” (NIH publication number 85-23, revised 1985) and the Guidelines of the Animal 
Investigation Committee, Chiba University. SMCs from the medial layer of the thoracic aorta of 
male Japanese white rabbits weighing ~2 kg were prepared using the explant method. Nembutal 
(Dainippon Sumitomo Pharma, Japan) was administered (25 mg/kg, i.v.) before the artery was 
extirpated. SMCs were cultured as described by Ishii et al. [6]. SMCs were treated with 
trypsin–EDTA for 1–2 minutes, and released SMCs were subcultured at 1 × 106 cells per dish 
(diameter, 10 cm) in 8 ml of 10% FBS/Dulbecco's modified Eagle’s medium (10% 
FBS-DMEM). Biochemical analyses (expression of -actin and doubling time in proliferation) 
were conducted on SMCs prior to use. SMCs were subcultured every 2–4 days, and the process 
was repeated when cells reached confluence. SMCs used in this study were passages 4–7. 
The following procedure was used to prepare hSMCs in honeycombs. First, cells 
cultured on plates were released by incubation with trypsin–EDTA and collected by 
centrifugation at 200 × g for 10 minutes at 25°C. Next, cells were suspended in 300–400 l of 
culture medium and incubated with honeycombs (5 × 5 × 2 mm, approximately 4 × 10
6
 cells per 
30 honeycombs) on a dish (diameter, 6 cm) for 1.5 hours at 37°C. Then, 5 ml of culture medium 
was added. The medium was changed every day.  
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Cell number measurements 
Cells were washed twice with PBS and released from plates by incubation with 
trypsin–EDTA at 37°C for 1 minute or from honeycombs by incubation with collagenase-I 
(Sigma–Aldrich) at 37°C for 30 minutes. After the cells were collected, cell number was 
determined using an improved Neubauer deep chamber hemocytometer. Cell viability was 
assessed by trypan blue exclusion. 
 
Incorporation of [
3
H]leucine  
 Cells were plated at 3 × 10
4
 cells per well (24-well plate) and incubated for 48 hours 
or cultured in honeycombs for 24 hours. These cells were incubated with [
3
H]leucine (5 Ci/ml, 
Moravec Biochemicals) for 1 hour. Collected cells were lysed with 10% trichloroacetic acid 
(TCA) and transferred to glass microfiber filter (Whatman). Radioactivity was determined using 
a liquid scintillation counter.  
 
Measurement of polyamines 
Polyamine contents in cells were determined as previously described [21]. Cells were 
treated with 5% TCA and centrifuged at 12,000 × g for 10 minutes. Polyamines in the 
supernatant were measured by using a TOSOH HPLC system (Tosoh, Tokyo, Japan). The 
precipitate was used to determine the protein content.  
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Western blotting 
Detection of eIF4A, 4B, 4E, 4G, 1, 1A, 2, 2, phospho-eIF2 (Ser52), cyclin 
dependent kinase 2 (CDK2), cyclin E1, D1, p27
Kip1
,p21Cip1, enhanced green fluorescent protein 
(EGFP) and -actin was carried out by western blotting analysis.  
Cells were washed twice with PBS and released from plates by incubation with 
trypsin–EDTA at 37°C for 1 minute or from honeycombs by incubation with collagenase-I at 
37°C for 30 minutes. SMCs were collected and washed twice with cold PBS. Cells were lysed 
in IP buffer (20 mM Tris–HCl, pH 7.4, 150 mM NaCl, 10 mM EDTA, 0.5% sodium cholate, 
0.5% Triton X-100, 0.1 mM FUT175, 0.1 mM E64-C, 5 mM NaF, and 0.5 mM Na3VO4) for 20 
minutes on ice. Cell lysates were centrifuged at 12,000 × g for 20 minutes, and protein 
concentrations were determined using a bicinchoninic acid protein assay reagent kit (Pierce). 
Bovine serum albumin was used as a standard in this assay. After lysates were separated on  
SDS-PAGE gels, proteins were transferred to an Immobilon membrane (Millipore) and 
immunoblotted with specific antibodies. Immunoblots were visualized using Immobilon™ 
Western (Millipore). The primary antibodies used for western blotting were polyclonal anti-eIF1 
antibody (Santa Cruz Biotechnology), polyclonal anti-eIF1A antibody (Abcam), polyclonal 
anti-eIF2 antibody (FL-315; Santa Cruz Biotechnology), polyclonal anti-phospho-eIF2 
antibody (Invitrogen), polyclonal anti-eIF2 antibody (Bethyl), polyclonal anti-CDK2 antibody 
(M2; Santa Cruz Biotechnology), polyclonal anti-cyclin E1 antibody (M-20; Santa Cruz 
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Biotechnology), polyclonal anti-p27
Kip1
 antibody (C-19; Santa Cruz Biotechnology), polyclonal 
anti-p21
Cip1
 antibody (C-19; Santa Cruz Biotechnology), monoclonal anti-cyclin D1 antibody 
(HD11; Santa Cruz Biotechnology),  polyclonal anti-GFP antibody (Medical & Biological 
Laboratories) and polyclonal anti--actin antibody (l-19; Santa Cruz Biotechnology). 
Monoclonal anti-eIF4A antibody and polyclonal anti-eIF4B antibody were kind gifts from Dr. 
Imataka H. Polyclonal anti-eIF4E and anti-eIF4G antibodies were kind gifts from Dr. Sonenberg 
N. Membranes were incubated with antibody for 1–3 hours. Membranes were treated with 
anti-mouse or anti-rabbit IgG (horseradish-peroxidase-linked species-specific antibody; GE 
Healthcare) as the secondary antibody for 30 minutes. For detection of eIF4G, samples were 
incubated with 3 ng/l 2A protease [22] at 4°C for 1 hour. 
 
Reverse transcription-polymerase chain reaction (RT-PCR)  
Total RNA was isolated from SMCs using mirVana miRNA Isolation Kit (Ambion) or 
TRIzol
® 
(Invitrogen). Before reverse transcription, contaminating plasmids were removed using 
DNA-free
TM 
(Ambion). cDNA was synthesized using 1 g RNA in 20 l of reaction mixture 
with Omniscript
®
 Reverse Transcription (QIAGEN). One microliter of reverse-transcribed 
cDNA was used in a total reaction volume of 25 l for PCR amplification using specific primers 
for eIF4B, 4G1 and EGFP. Amplification of glycerol-3-phosphate dehydrogenase (GAPDH) 
was used as a control. The following primer pairs were used: forward primer for eIF4B, 
5'-GAACCCAGCAATCCAGAGAG-3'; reverse primer for eIF4B, 
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5'-CGATACCCACTGCCAAATG-3'; forward primer for eIF4G1, 
5'-CCGAATTCGAGATCCAAACC-3'; reverse primer for eIF4G1, 
5'-AAGACTGGGGATGGTGATGG-3'; forward primer for EGFP, 
5’-AGGAGCGCACCATCTTCTTC-3’; reverse primer for EGFP, 
5’-GATGTTGTGGCGGATCTTGA-3’; forward primer for GAPDH, 
5'-CATCACTGCCACCCAGAAGA-3'; reverse primer for GAPDH, 
5'-CTGGTGCTCAGTGTAGCCCA-3'. Reaction products were analyzed by electrophoresis on 
2% agarose gels and observed with ultraviolet transillumination after ethidium bromide staining. 
PCR cycling was as follows: initial denaturation at 94°C for 1 minute (one cycle), denaturation 
at 94°C for 10 seconds, annealing by Taq polymerase (Takara Bio Incorporated) at 67°C for 
eIF4B, at 64°C for eIF4G1, at 67°C for EGFP, or at 66.7°C for GAPDH for 10 seconds and 
elongation at 72°C for 30 seconds. The number of amplification cycles performed for eIF4B, 
eIF4G1, EGFP and GAPDH were 26, 26, 23 and 21 respectively.  
 
Transient transfection of eIF4B-EGFP fusion gene 
206 bp of the 5’-UTR and 99 bp of the open reading flame of the eIF4B gene 
(NM_001417.4) was synthesized by Invitrogen. Fusion gene was inserted into the BamHI and 
EcoRI restriction sites of pEGFP-N1 (Clonetech). Rabbit SMCs cultured on plates (diameter, 6 
cm) were transfected with 3 g of plasmids using Lipofectamine® 2000 (Invitrogen) according 
to the accompanied manual for 6 hours. The cells were further cultured with 0.5 mM 
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-difluoromethylornithine (DFMO) and 0.1 mM ethylglyoxal-bis-guanylhydrazone (EGBG) for 
24 hours. Whether fusion gene was expressed or not was determined of EGFP by RT-PCR and 
western blotting.  
 
Statistical analysis 
The statistical
 
significance of differences was assessed by the unpaired t-test using 
JSTAT. 
 
 
Results 
 Growth of human SMCs cultured on plates and in honeycombs 
 Cell number of human aortic SMCs (hSMCs) was investigated to determine whether 
hSMCs proliferate when they were cultured in honeycombs. We used two lots of hSMCs for the 
experiments; each lot was derived from a 20 and a 36 year-old man. hSMCs cultured on plates 
proliferated rapidly till they became confluent (Fig. 1A). hSMCs cultured in honeycombs 
adhered across the lumen of the honeycombs as well as rabbit SMCs did (data not shown). Cell 
number of hSMCs cultured in honeycombs did not change (Fig. 1A). Expression of proteins 
related to cell cycle was detected (Fig. 1B). Expressions of CDK2 and cyclin E1 decreased in 
hSMCs cultured in honeycombs, indicating that hSMCs stopped proliferating. However, 
expression of p21
Cip1
 was reduced from day 1, and that of p27
Kip1
 increased after hSMCs 
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stopped proliferating in honeycombs. SMCs derived from p27
Kip1
 knockout mice also stopped 
proliferating when cultured in honeycombs (unpublished data). These data indicate that cyclin 
dependent kinase inhibitors may not contribute to rapid growth inhibition of hSMCs in 
honeycombs. It has been recently reported that miR143 and 145 have important role in 
proliferation and differentiation of SMCs [23]. Expressions of these micro RNAs in hSMCs 
cultured in honeycombs did not change (data not shown). From these results, it is assumed that 
other factors play pivotal roles in proliferative inhibition of hSMCs cultured in honeycombs. 
 
 Changes in the expressions of eukaryotic initiation factors in hSMCs 
 We focused on protein synthesis in hSMCs because our previous data has shown that 
protein synthesis was reduced in rabbit SMCs cultured in honeycombs [6]. This might be related 
to proliferative inhibition of SMCs cultured in honeycombs. As shown in Fig. 2A, incorporation 
of [
3
H]leucine in hSMCs cultured in honeycombs for 24 hours decreased compared to that in 
subconfluent hSMCs on plates. Protein content in hSMCs cultured in honeycombs for 24 hours 
was 74% of that in hSMCs cultured on plates. These results indicate that protein synthesis was 
inhibited in honeycombs. Changes in the expressions of eukaryotic initiation factors (eIFs) were 
investigated (Fig. 2B). Among eIFs, protein expressions of eIF4B and 4G were dramatically 
decreased in hSMCs cultured in honeycombs although mRNA levels in hSMCs cultured in 
honeycombs were almost the same as those in hSMCs cultured on plates (Fig. 2C). For eIF2 to 
promote a new round of translation initiation, GDP needs to be exchanged for GTP by eIF2B. 
16 
 
Phosphorylation of eIF2 stabilizes eIF2-GDP-eIF2B complex, inhibiting the turnover of eIF2B 
[24]. Phosphorylation of eIF2 was increased in hSMCs in honeycombs. These results strongly 
suggest that protein synthesis in hSMCs cultured in honeycombs was reduced as a result of 
inhibition of translation initiation. 
 
 Intracellular polyamine and phosphorylation of eIF2
 Next, we investigated the regulation of eIFs in hSMCs cultured in honeycombs. 
Phosphorylation of eIF2 in hSMCs cultured in honeycombs was increased from 6 hour (Fig. 
3B). It has been reported that polyamine depletion induced eIF2 phosphorylation in 
mammalian cells [25]. Intracellular polyamine contents in hSMCs cultured in honeycombs were 
detected (Fig. 3A). Putrescine and spermidine contents in hSMCs cultured in honeycombs were 
increased within 12 hours and then decreased to the same levels of those at 0 hour. Level of 
spermine was gradually decreased. In rabbit SMCs, each polyamine content in honeycombs was 
lower than those in SMCs on plates [20], and phosphorylation of eIF2 was increased (data not 
shown). It is known that effects of spermine are greater than spermidine or putrescine [26, 27]. 
Thus, we focused on the decrease in spermine content in hSMCs. When DFMO (inhibitor of 
ornithine decarboxylase) was added to hSMCs cultured on plates in combination with EGBG 
(inhibitor of S-adenosylmethionine decarboxylase), spermine content was decreased as the same 
level as that observed in hSMCs cultured in honeycombs (Fig. 3C). eIF2 phosphorylation was 
increased when hSMCs cultured on plates were treated with DFMO and EGBG (Fig. 3D). 
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Although spermidine content was decreased when hSMCs cultured on plates were incubated 
only with DFMO, eIF2 phosphorylation did not change (data not shown). These data suggest 
that spermine content may be one of the important factors regulating phosphorylation of 
eIF2in SMCs cultured in honeycombs.       

 Effects of polyamine on synthesis of eIF4B 
 From the results presented in Fig. 2B and C, expressions of eIF4B and 4G were 
regulated after transcription. Recent study has shown that syntheses of certain proteins were 
preferentially enhanced by polyamines at the level of translation in mammalian cells [19]. To 
study the effects of polyamine on translation of eIF4B, a fusion gene containing 206 bp of the 
5’-UTR and 99 bp of the open reading flame of the eIF4B gene fused to the EGFP gene was 
transiently transfected into rabbit SMCs cultured on plates (Fig. 4A). When intracellular 
spermine content was decreased by treating with DFMO and EGBG (Fig. 4B), both mRNA and 
protein levels of EGFP did not change (Fig. 4C and D). However, when spermine content was 
decreased, protein expression of eIF4B-EGFP was decreased although mRNA levels did not 
change (Fig. 4C and D), indicating that synthesis of eIF4B was regulated by polyamine at the 
level of translation. This suggests that a decrease in spermine level might induce translational 
inhibition of eIF4B in SMCs cultured in honeycombs.  
 
 Degradation of eIF4B and eIF4G in hSMCs cultured in honeycombs 
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We examined whether degradation of eIF4B and 4G was promoted in hSMCs cultured 
in honeycombs (Fig. 5). hSMCs were cultured on plates with or without cycloheximide to 
evaluate the half-life of eIF4B and 4G. Cyclin D1 was used for a positive control of 
cycloheximide treatment [28]. The result showed that half-life of both eIF4B and 4G was longer 
than 24 hours in hSMCs cultured on plates. However, expressions of eIF4B and 4G decreased 
within 6 hours of hSMCs being cultured in honeycombs. This indicates that degradation of 
eIF4B and 4G was promoted in hSMCs cultured in honeycombs.   
 
Expressions of eukaryotic initiation factors in aortic media 
Expressions of eIFs in aortic media derived from Japanese white rabbit were 
investigated (Fig. 6). Expressions of eIF4A, 4B, 4E, 4G and 2 of aortic media were lower than 
primary cultured rabbit SMCs cultured on plates, whereas ratio of p-eIF2 to eIF2was higher. 
Expression patterns of eIFs in rabbit SMCs cultured in honeycombs were similar to those in 
aortic media or intermediate between aortic media and SMCs cultured on plates. This suggests 
that SMCs cultured in honeycombs are more similar to differentiated SMCs. 
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Discussion 
 In this section, we investigated the regulation of eukaryotic initiation factors in human 
SMCs. We propose that regulation of eIFs (phosphorylation, translation and degradation) 
decrease protein synthesis, inducing proliferative inhibition of SMCs cultured in honeycombs. 
 Our previous study has shown that polyamine contents in rabbit SMCs cultured in 
honeycombs were lower than those in SMCs cultured on plates [20]. On the other hand, 
spermine content was decreased in human SMCs cultured in honeycombs. We expect that a 
decrease in spermine content is one of the factors for stimulation of eIF2 phosphorylation and 
inhibition of eIF4B protein synthesis at the level of translation. eIF2 is known to be 
phosphorylated by interferon inducible double stranded RNA dependent protein kinase (PKR, 
activated by double stranded RNA and viral infection) [29], heme-regulated inhibitor (HRI, 
activated by low heme levels) [30], general control nonderepressible 2 (GCN2, activated by 
amino acid starvation) [31], and protein kinase RNA-like endoplasmic reticulum kinase [PERK, 
activated by endoplasmic reticulum (ER) stress] [29]. It is unknown that which enzyme is the 
main contributor for phosphorylation of eIF2 and how polyamines influence the 
phosphorylation of eIF2in SMCs. Transient ER stress which is caused by nutrient deprivation 
or hypoxia may occur in SMCs cultured in honeycombs because a large number of cells were in 
a small amount of culture medium for first several hours after beginning the culture in 
honeycombs. It is also assumed that SMCs cultured in honeycombs may scarcely take 
exogenous nutrition as exogenous polyamine transport was restricted in SMCs cultured in 
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honeycombs [20]. But further studies are needed.  
Polyamines enhance the synthesis of certain proteins preferentially at the level of 
translation [19, 32]. The possible mechanism is that polyamines enhance ribosomal shunting on 
the 5’-UTR of mRNA. Ribosomal shunting is a model in which a ribosome bypasses a region of 
stable secondary structure in the mRNA by first dissociating from the RNA at a ‘take-off’ 
element upstream of the blocking structure, and then reassociating with mRNA downstream of 
the structure, at a ‘landing site’ element [33, 34]. On the 5’-UTR of eIF4B mRNA, there are 
three hairpin structures (Fig. 4A) and candidate sequences for ‘take-off’ and ‘landing site’ 
around each hairpin (data not shown). So, we removed each hairpin structure independently 
from eIF4B-EGFP mRNA, and the effects of polyamines were examined. The protein 
expressions of eIF4B-EGFP from mRNAs in which hairpin structure was removed were 
decreased by treatment with DFMO and EGBG at the level of translation (data not shown). It 
was unlikely that polyamines enhance ribosomal shunting on the 5’-UTR of eIF4B-EGFP 
mRNA. Expression of EGFP, whose 5’-UTR is much shorter than that of eIF4B-EGFP and has 
only one hairpin structure in it, was not influenced by polyamines (Fig. 4C and D). Effects of 
polyamines on translation may be dependent on length or secondary structure of the 5’-UTR.  
Degradation of eIF4B and 4G was promoted in SMCs cultured in honeycombs (Fig. 5), 
whereas that of the other eIFs (4A, 2 and 2) was not (data not shown). Degradation of focal 
adhesion kinase (FAK), which expression and phosphorylation are important for proliferation 
and focal adhesion turnover in SMCs [35], was also enhanced when SMCs were cultured in 
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honeycombs (data not shown). Moreover, degradation of filamin, which is an actin binding 
protein, was also increased (shown in chapter 2). From these things, there is a possibility that 
degradation pathways are stimulated after SMCs attach to honeycomb wall, and that these 
pathways work on specific proteins. Previous studies have shown that eIF4B and 4G are 
degraded during apoptosis by caspase 3 [36, 37]. However, pre-incubation of caspase inhibitor 
(Z-VAD-fmk) had no effects on the degradation of eIF4B and 4G in SMCs cultured in 
honeycombs (data not shown). Further studies are needed to know what kinds of proteases are 
activated when SMCs were cultured in honeycombs. 
Silencing of eIF4B or 4G mRNA by short interfering RNA reduces protein synthesis 
approximately to 50 % in HeLa cells [38, 39]. eIF4B regulates translation through stimulation 
of the helicase activity of eIF4A by several mechanisms [40]. It has been reported that eIF4B 
silencing led to decreased proliferation rate in mammalian cells [38]. Interestingly, in eIF4B 
siRNA-transfected cells, selective reduction of translation was observed for mRNAs harboring 
strong to moderate secondary structures in their 5’-UTRs [38]. These mRNAs encode proteins 
which function is cell proliferation and survival. Decreasing expression of eIF4B in SMCs 
cultured in honeycombs may lead to selective translational inhibition of mRNAs which encode 
proteins involved in proliferation.   
When SMCs are cultured in honeycombs, dramatic changes occur within 24 hours. 
After attachment to honeycomb walls, intracellular polyamine contents were changed through 
unknown mechanism. This may induce eIF2 phosphorylation. Change in polyamine content 
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may also affect translation of mRNAs whose 5’-UTRs are relatively long or highly structured 
such as the 5’-UTR of eIF4B. Moreover, degradation pathways are stimulated. Degradation of 
eIF4B could lead to selective translational inhibition of mRNAs. It is suggested that eIF2 
phosphorylation and reduced expressions of eIF4B and 4G result in inhibition of protein 
synthesis at the level of translation. This might contribute to rapid proliferative inhibition in 
SMCs cultured in honeycombs.  
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Fig. 1. Growth of human SMCs cultured on plates and in honeycombs. Two lots of hSMCs 
(lot 1, age 20; lot 2, age 36) were cultured on plates or in honeycombs. (A) Cell number of 
hSMCs. □, hSMC1 on plates; ■, hSMC2 on plates; ○, hSMC1 in honeycombs; ●, hSMC2 
in honeycombs. (B) Western blot analysis of cell cycle related proteins.  
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Fig. 2. Expression of eukaryotic initiation factors in hSMCs. (A) Incorporation of 
[
3
H]leucine. Subconfluent hSMCs or hSMCs cultured in honeycombs for 24 hours were 
incubated with [
3
H]leucine for 1 hour. Values are mean ±SE. **p<0.01. (B) Western 
blot analysis of eukaryotic initiation factors. Two lots of hSMCs were cultured on plates 
or in honeycombs. (C) RT-PCR analysis of eIF4B and 4G.  
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Fig. 3. Effects of polyamine on phosphorylation of eIF2. (A) Intracellular polyamine 
contents in hSMCs cultured in honeycombs. △, putrescine; ○, spermidine ; ■, 
spermine. (B) Western blot analysis of eIF2in hSMCs cultured in honeycombs. (C) 
Intracellular polyamine contents in hSMCs cultured on plates treated with DFMO and 
EGBG for 24 hours. △, putrescine; ○, spermidine; ■, spermine. (D) Western blot 
analysis of eIF2in hSMCs cultured on plates treated with DFMO and EGBG for 24 
hours.  
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Fig. 4. Effects of polyamine on translation of eIF4B. Rabbit SMCs on plates were treated 
with or without DFMO and EGBG for 24 hours after transient transfection of eIF4B-EGFP 
fusion gene encoding 5’-UTR of eIF4B mRNA, 33 amino acids of the amino terminal end of 
eIF4B protein, and full length of EGFP protein for 6 hours. (A) Optimal computer folding of 
the 5’-UTR of eIF4B were performed according to the method of Zuker (MFOLD 3.2). (B) 
Intracellular polyamine contents in rabbit SMCs treated with or without DFMO and EGBG for 
24 hours, after transient transfection of the fusion gene. △, putrescine; ○, spermidine ; ■, 
spermine. (C) RT-PCR of EGFP. (E) Western blot analysis of EGFP. 
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Fig. 5. Cycloheximide chase assay in hSMCs. hSMCs were cultured on plates with or 
without 20 g/ml cycloheximide for 24 hours, or cultured in honeycombs for 12 hours. CHX, 
cycloheximide. 
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Fig. 6. Expressions of eukaryotic initiation factors in aortic media. Plate: SMCs derived 
from Japanese white rabbits were cultured on plates. Honeycomb: rabbit SMCs were 
cultured in honeycombs. Aortic media: aortic media derived from Japanese white rabbits was 
homogenized. 
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Chapter 2 
Degradation of filamin induces contraction of vascular smooth muscle cells in type-I 
collagen matrix honeycombs 
 
SMCs in honeycombs are attached across the lumens of the honeycombs by a few 
adhesion points and have a more spindly shape than do SMCs cultured on plastic plates. We 
have previously reported that formation of cellular cross-bridges in honeycombs is important for 
changes that occur in SMCs grown in honeycombs [41]. This suggests that relationships exist 
between the structural rearrangement of the cytoskeleton and specific features of SMCs cultured 
in honeycombs.  
It has been demonstrated that SMCs derived from freshly isolated gizzard smooth 
muscle strips possess a structural lattice that is composed of a contractile apparatus and a 
cytoskeleton (-non-muscle actin filaments, intermediate filaments and dense bodies) [42, 43]. 
The main components of the contractile apparatus are known to be -smooth muscle actin 
(-actin), myosin, tropomyosin, calponin, caldesmon and myosin light chain kinase, while the 
cytoskeleton is mainly constructed of -non-muscle actin (-actin) filaments, filamin, calponin 
and vimentin. Dense bodies are composed of -actin, -actinin and calponin [44]. Of these 
proteins, -actinin, an actin-binding protein localized to dense bodies and adherens junctions 
that is involved in bundling of actin filaments [43, 45, 46], and filamin, an actin cross-linking 
protein, are thought to affect the arrangement of actin filaments. . 
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Three filamin genes (FLNA, FLNB and FLNC) have been identified in humans [47]. 
Filamin A has a molecular weight of 280 kDa and a molecular length of approximately 160 nm 
[48]. Filamin A consists of an N-terminal actin-binding domain (ABD) and a rod-like domain of 
24 repeats, which is interrupted by 30-amino-acid long flexible loops, H1 (between repeats 15 
and 16) and H2 (between repeats 23 and 24). The last repeat, repeat 24, represents the 
self-association domain of the molecule. Filamin dimers link actin filaments into orthogonal 
networks or parallel bundles, and an in vitro study has shown that the manner in which actin 
filaments are organized depends on the ratio of filamin to actin [49]. It has also been reported 
that filamin co-localizes with the non-muscle actin cytoskeleton and intermediate filaments, but 
not with the contractile apparatus, in SMCs derived from freshly isolated gizzard smooth 
muscle strips [42, 43]; these findings indicate that filamin mainly interacts with the 
-non-muscle actin filaments in SMCs.  
In the present study, we hypothesized that filamin would be expected to influence the 
arrangement of the cytoskeletal structure in SMCs. Filamin is known to be degraded at H1 and 
H2 sites by Ca
2+
-dependent proteases known as calpains [50], including -calpain and 
m-calpain, which are ubiquitously expressed [51, 52]. We therefore investigated whether filamin 
in SMCs was degraded by calpain and whether SMCs cultured in honeycombs could contract. 
We also discuss the relationship between filamin and phenotypic changes in SMCs.      
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Materials and Methods 
Honeycomb collagen tubes 
Honeycomb collagen tube using for this section was same as chapter 1. The 
honeycombs were cut vertically into cubes of dimensions 4 × 4 × 2 mm or 6 × 6 × 2 mm. 
 
Cell culture 
Method for culture of rabbit SMCs was same as chapter 1. 
NIH3T3 cells were cultured in 10% FBS-DMEM under standard cell culture 
conditions (37°C, 5% CO2). Human umbilical vein endothelial cells (HUVEC, Lonza) were 
cultured under standard cell culture conditions (37°C, 5% CO2) in endothelial basal medium 2 
(EBM2, Lonza) supplemented with hFGF-B, human recombinant vascular endothelial growth 
factor (VEGF), hEGF, hydrocortisone, heparin, ascorbic acid, R3-insulin-like growth factor-1, 
gentamicin/amphotericin B (GA) and 2% FBS, as suggested by the supplier.  
The following procedure was used to prepare cells in honeycombs. First, cells cultured 
on plates were released by incubation with trypsin–EDTA and collected by centrifugation at 200 
× g for 10 minutes at 25°C. Next, cells were suspended in 300–400 l of culture medium and 
incubated with honeycombs (4 × 4 × 2 or 6 × 6 × 2 mm, 2 × 10
6
 cells per 30 honeycombs) on a 
dish (diameter, 6 cm) for 3 hours at 37°C. Then, 3–4 ml of culture medium was added. The 
medium was changed every 2–3 days. ALLN was obtained from Calbiochem and added to 10% 
FBS-DMEM for experiments. 
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Cell number measurements 
Method for cell number measurements was same as chapter 1. 
 
Determination of honeycomb area 
Honeycombs (6 × 6 × 2 mm) were incubated with or without cells for 0–7 days in 
culture medium. At days 0, 1, 3and 7, pictures were taken of the honeycombs, with or without 
cells, immersed in medium in dishes (diameter, 6 cm) using a digital camera (Canon). The 
photographs were enlarged, and the areas (length × width) of the honeycombs were calculated 
using Image J 1.41. 
 
Subcellular fractionation 
Triton X-100-soluble (cytoplasmic) and -insoluble
 
(cytoskeletal) fractions were 
prepared as previously described
 
[35].  
 
Western blotting 
Method for western blot was same as chapter 1.The primary antibodies used for 
western blotting were monoclonal anti-filamin antibody (1.BB.804; Abcam), polyclonal 
anti-calpain 1 (-calpain) antibody (H-65; Santa Cruz Biotechnology), polyclonal anti-calpain II 
(m-calpain) antibody (Chemicon International), polyclonal anti--actinin antibody (H-300; 
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Santa Cruz Biotechnology), polyclonal anti--actin antibody (l-19; Santa Cruz Biotechnology), 
polyclonal anti-phosphor-filamin A (Ser
2152
) (Cell Signaling), monoclonal anti-calpastatin 
antibody (PI-11; Santa Cruz Biotechnology), monoclonal anti-vimentin antibody (V9; 
Sigma–Aldrich), monoclonal anti--actin antibody (1A4; DAKO), monoclonal anti-myosin 
(smooth) antibody (HSM-V; Sigma–Aldrich) and monoclonal anti-tropomyosin antibody 
(TM311; Sigma–Aldrich).  
 
Northern blotting  
Total RNA was isolated from SMCs using Isogen reagent (Isogen International). Ten 
micrograms of total RNA was fractionated by electrophoresis in a 1% agarose gel containing 
400 mM formaldehyde. RNA was transferred to a Hybond N
+
 membrane (Amersham) by 
capillary transfer overnight and fixed to the membrane by UV crosslinking. Polymerase chain 
reaction (PCR)-derived probes for filamin A were prepared from the total cDNA of SMCs using 
a DIG DNA Labeling Kit (Roche). The primer pairs for probes were as follows: forward primer, 
5'-GGGTCACCTACTGCCCCAC-3'; reverse primer, 5'-GGATCTTGAGGCTGAGGTCG-3'. 
DIG Easy Hyb (Roche), DIG Wash and Block Buffer Set (Roche), DIG Luminescent Detection 
Kit (Roche) and CDP-Star ready-to-use (Roche) were used for hybridization. Detection was 
carried out according to the manufacturer’s protocol. 
 
RT-PCR  
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Total RNA was isolated from SMCs using Isogen reagent. cDNA was synthesized 
using 1 g RNA in 20 l of reaction mixture with Omniscript® Reverse Transcription 
(QIAGEN). One microliter of reverse-transcribed cDNA was used in a total reaction volume of 
25 l for PCR amplification using specific primers for filamin A. Amplification of 
glycerol-3-phosphate dehydrogenase (GAPDH) was used as a control. The following primer 
pairs were used: forward and reverse primers for filamin A were the same as those used for 
northern blotting; forward primer for GAPDH, 5'-G ATGCCCCCATGTTTGTGAT-3'; reverse 
primer for GAPDH, 5'-AAGGCCATGCCAGTGAGTTT-3'. Reaction products were analyzed 
by electrophoresis on 2% agarose gels and observed with ultraviolet transillumination after 
ethidium bromide staining. PCR cycling was as follows: initial denaturation at 94°C for 1 
minute (one cycle), denaturation at 94°C for 10 seconds, annealing by Taq polymerase (Takara 
Bio Incorporated) at 69.3°C for filamin A or at 66.2°C for GAPDH for 10 seconds and 
elongation at 72°C for 30 seconds. The number of amplification cycles performed for filamin A 
and GAPDH were 27 and 22 respectively.  
 
Immunofluorescence  
SMCs on coverslips or in honeycombs were fixed in 3.7% formaldehyde in PBS for 
10 minutes. Fixed cells were permeabilized with 0.1% Triton X-100 in PBS for 10 minutes and 
pre-incubated with 10% normal goat serum (Wako) for 10 minutes to block non-specific 
binding. These cells were then incubated with monoclonal anti-filamin antibody (1.BB.804; 
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Abcam) or monoclonal anti--actin antibody (1A4; DAKO) and polyclonal anti--actin 
antibody (l-19; Santa Cruz Biotechnology) for 3 hours. This was followed by incubation with 
FITC-conjugated anti-mouse IgG (Sigma–Aldrich) and TRITC-conjugated anti-rabbit IgG 
(Sigma–Aldrich) for 1 hour. Immunofluorescence was observed using a Fluoview FV500 
(Olympus) laser-scanning microscope with a 60 × 1.00 NA water immersion objective. Images 
were digitally processed using Adobe Photoshop Elements 4.0 software (Adobe). 
 
Statistical analysis 
The statistical
 
significance of differences was assessed by Tukey's test in Fig. 7B and 
D, and Dunnett's test in Fig. 7C. Data are mean ± SE.  
 
 
Results  
Shrinkage of honeycombs used for culturing SMCs 
Changes in the size of the honeycombs used for culturing SMCs and other 
non-contractile cells (NIH3T3 cells and HUVECs) were investigated to determine whether 
SMCs cultured in honeycombs can contract. SMCs mainly cross perpendicular to the pore of the 
honeycombs; therefore, it was expected that the height of honeycombs would not be 
dramatically changed by SMCs. Honeycomb size (length × width) was measured as honeycomb 
area (Fig. 7A). NIH3T3 cells were attached across the lumens of the honeycombs, while 
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HUVEC were attached to the walls of honeycombs and maintained a round shape, similar to 
that seen when they are grown on plates. NIH3T3 cells proliferated rapidly in honeycombs, 
reaching confluence on day 3, while the number of SMCs and HUVEC in the honeycombs did 
not change (Fig. 7B). The area of the honeycombs was reduced after culturing each cell-type 
(Fig. 7C). Moreover, the honeycomb areas of SMC cultures were reduced to a greater extent 
each day than the honeycomb areas of the other two cell-types (Fig. 7D). This suggests that the 
reduced honeycomb area in SMCs is caused by the tension of SMCs attached across the lumen 
of the honeycombs or that these SMCs have contractile activity. Expression of proteins involved 
in both the contractile apparatus and the cytoskeleton were detected in SMCs cultured in 
honeycombs (Fig. 7E). Expression of -actin, smooth muscle myosin heavy chain (MHC), and 
tropomyosin (components of the contractile apparatus) was almost the same in SMCs cultured 
in honeycombs as in SMCs at day 0. Among components of the cytoskeleton, expression of 
-actin and -actinin were unchanged. SMCs at day 0 expressed the 280 kDa form of filamin, 
whereas SMCs cultured in honeycombs expressed both the 280 and 180 kDa forms of filamin. 
We hypothesized that there might be some relationship between changes in the molecular 
weight of filamin and contraction of SMCs in honeycombs. 
 
Changes in the molecular weight of filamin in SMCs cultured under different 
conditions 
As shown in Fig. 8A, filamin is abundantly expressed in the aortic media derived from 
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Japanese white rabbits, suggesting that filamin has an important role in SMCs. Changes in the 
molecular weight of filamin in SMCs cultured under different conditions were investigated (Fig. 
8B). At 0 hours, the molecular weight of filamin was mainly 280 kDa. After SMCs were 
cultured for 6 hours in honeycombs, however, filamin with molecular weights of both 280 and 
180 kDa were observed (Fig. 8B). Moreover, SMCs in honeycombs were spindle-shaped, 
adhered across the lumen of the honeycombs and stopped proliferating (data not shown). The 
viability of these cells at 12, 24 and 48 hours was 85, 85 and 86%, respectively. These data are 
consisted with our previous study [6]. SMCs cultured on plates proliferated and became 
confluent on day 7 (data not shown). The viability of the SMCs grown on plates on day 3, 7 and 
14 was 88, 78 and 84%, respectively. Subconfluent SMCs cultured on plates mainly expressed 
filamin with a molecular weight of 280 kDa, but two types of filamin were apparent after these 
cells became confluent (Fig. 8B). Subconfluent SMCs were widely spread on plates, while 
confluent SMCs had a spindly shape. The aortic media of Japanese white rabbits expressed 
filamin of both 280 and 180 kDa (Fig. 8C), and this pattern was identical to that of filamin in 
SMCs cultured in honeycombs. The filamin antibody used in this experiment does not 
distinguish between filamin isoforms, but matrix-assisted laser desorption ionization 
time-of-flight tandem mass spectrometry (MALDI-TOF/TOF MS) analysis using an AB4700 
mass spectrometer (Applied Biosystems) confirmed that the 280 and 180 kDa forms of filamin 
in SMCs were the filamin A isoform (data not shown). -Calpain and m-calpain were expressed 
in SMCs under each of the culture conditions described above and expression of -actinin and 
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-actin was not altered by different culture conditions. 
 
Degradation of filamin 
To begin investigating how the molecular weight of filamin changed in SMCs, we 
initially examined whether this process involves regulation at the transcriptional level.  
Filamin A mRNA was detected by northern blot analysis of total RNA isolated from 
subconfluent and confluent SMCs cultured on plates (Fig. 9A and B). Results from this study 
indicated that both the subconfluent and confluent SMCs expressed filamin A mRNA of only 
one size (~8.1 kb). Filamin transcripts in humans and mice are reported to be 8–9.5 kb and 
9.5–10 kb, respectively [50, 53, 54]. Filamin A mRNA therefore appears to encode the entire 
filamin molecule; thus, it is likely that the change in the molecular weight of filamin observed in 
SMCs occurs after translation.  
We next examined whether filamin was degraded by calpain in SMCs. Filamin 
expression was not altered upon incubated with 2 M ALLN (N-Acetyl-Leu-Leu-Nle-CHO), an 
inhibitor of calpain, in subconfluent SMCs cultured on plates (Fig. 9C). In contrast, the change 
in the molecular weight of filamin was suppressed by 2 M ALLN when confluent SMCs on 
plates at day 8 were incubated with 2 M ALLN (Fig. 9D). These results indicate that filamin is 
degraded by calpain. When SMCs were cultured in honeycombs, filamin degradation was not 
suppressed by ALLN, even though SMCs cultured in honeycombs were incubated with 2 M 
ALLN from day 1 (data not shown). The lack of an effect of ALLN on filamin degradation in 
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this study might be due to the fact that ALLN was not incorporated into SMCs cultured in 
honeycombs. Next, SMCs were pre-incubated with 2 M ALLN for 24 hours while still 
cultured on plates and then transferred to honeycombs with 2 M ALLN; however, filamin 
degradation by calpain was still not suppressed by ALLN (Fig. 9E). When the concentration of 
ALLN was increased to 50 M, most SMCs died, but living cells in honeycombs expressed 
filamin with molecular weights of both 280 and 180 kDa (data not shown).  
 
Phosphorylation of filamin A and the presence of calpastatin 
Next, we examined the regulation of filamin degradation in SMCs. Filamin is known 
to be degraded by calpain at residues 1761-1762 in the H1 region. As a result, filamin is divided 
into 2 fragments of 180 kDa and 100 kDa [50]. Phosphorylation of the Ser2152 residue of filamin 
A has been reported to be responsible for the degradation of filamin A by calpain in platelets [55, 
56]. Thus, the phosphorylation status of filamin A in SMCs cultured on plates and in 
honeycombs was investigated. The monoclonal antibody for filamin detects both full-length 
filamin and a degraded filamin fragment of 180 kDa. Conversely, the anti-phospho-filamin A 
(Ser
2152
) antibody detects the full-length and 100 kDa fragment of phosphorylated filamin A 
because the Ser
2152
 residue is in the 100 kDa fragment. As shown in Fig. 10, the 280 kDa form 
of filamin A and a degraded filamin A fragment of 100 kDa were detected in SMCs. 
Phosphorylation of the 280 kDa filamin A was not changed when filamin degradation occurred 
in SMCs cultured on plates (days 3, 6 and 14) or in honeycombs (days 0, 1 and 2). These results 
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suggest that phosphorylation of the Ser
2152
 residue of filamin A is not responsible for the 
degradation of filamin A by calpain in SMCs under the conditions used in this study.  
Calpastatin is known to be an endogenous inhibitor of calpain [57]; therefore, the 
relationship between presence of calpastatin and appearance of the 180 kDa filamin was 
investigated in SMCs. Calpastatin was present when 180 kDa filamin was absent in SMCs 
cultured on plates and in honeycombs (Fig. 10). Moreover, when the 180 kDa filamin appeared, 
calpastatin disappeared. Calpastatin mRNA levels were almost the same in subconfluent SMCs 
cultured on plates and those cultured in honeycombs, which did and did not express calpastatin 
protein, respectively (data not shown). These results suggest that filamin degradation in SMCs 
might be regulated by calpastatin expression. 
 
Localization of filamin and -non-muscle actin filaments in SMCs 
Previous studies have shown that filamin mainly interacts with -non-muscle actin 
filaments in SMCs [42, 43]. To clarify the intracellular distribution of filamin after degradation, 
we examined filamin and -actin expression by immunofluorescence microscopy in SMCs. 
Filamin immunoreactivity was observed along fibers and co-localized with -actin 
immunoreactivity in subconfluent SMCs cultured on plates (Fig. 11A and B). When SMCs were 
incubated with 0.5 M cytochalasin D, this co-localization was disrupted, and both filamin and 
-actin were widely dispersed in the cytoplasm (Fig. 11C), suggesting that filamin interacts with 
-non-muscle actin filaments. In honeycombs, filamin staining was evenly detected in the 
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cytoplasm and was not stained as fibers in most cells (Fig. 11D and E). A small amount of 
filamin was co-localized with -actin in a few cells (data not shown).  
As shown in Fig. 11F, only the 280 kDa form of filamin was detected in whole cell 
lysates of subconfluent SMCs cultured on plates, and it was mainly detected in the Triton 
X-100-insoluble (cytoskeletal) fraction. In honeycombs, both the 280 and 180 kDa forms of 
filamin were detected in whole cell lysates. Expression of the 180 kDa form of filamin in the 
Triton X-100-soluble (cytoplasmic) fraction was greater than that in the insoluble fraction, 
whereas the 280 kDa form of filamin was mainly detected in the insoluble fraction. Although 
-actin expression was greater in the Triton X-100-insoluble fraction than in the soluble fraction 
in subconfluent SMCs grown on plates, expression of -actin in SMCs cultured in honeycombs 
was almost the same in the Triton X-100-soluble and -insoluble fractions. -Calpain was 
detected only in the Triton X-100-soluble fraction. Vimentin, a major component of 
intermediate filaments, was mainly seen in the Triton X-100-insoluble fraction, as expected [58]. 
Based on the results presented in Fig. 11, it can be assumed that degraded filamin, which does 
not bind to -non-muscle actin filaments, is present in the cytoplasmic fraction in SMCs 
cultured in honeycombs.  
 
Expression and localization of filamin and -actin in ODC-SMCs  
Recently, we stably overexpressed the rat ornithine-decarboxylase gene in SMCs 
(termed ‘ODC-SMCs’) to study the function of polyamine and ODC-antizyme in SMCs [20]. 
42 
 
Interestingly, expression of filamin was dramatically decreased in ODC-SMCs compared to 
SMCs (Fig. 12A). In ODC-SMCs cultured on plates, -non-muscle actin filaments were thinner 
than those of SMCs, although expression of -actin, as detected by western blotting analysis, 
was almost the same in SMCs and ODC-SMCs (Fig. 12B, C, D and E). Additionally, 
-non-muscle actin filaments were thicker in a few ODC-SMCs. In these cells, stronger filamin 
immunoreactivity was observed along fibers (Fig. 12F). These results suggest that the 280 kDa 
form of filamin is responsible for bundling of -non-muscle actin filaments in SMCs. It has 
been reported that filamin lacking a self-association domain cannot induce bundling of actin 
filaments in vitro [48]. These data indicate that degradation of filamin in SMCs cultured in 
honeycombs induces relative structural weakness of -non-muscle actin filaments. 
In subconfluent SMCs cultured on plates or in SMCs cultured in honeycombs, - and 
-actin were co-localized (Fig. 13), suggesting that the contractile apparatus was aligned with 
-non-muscle actin filaments. These findings show that degradation of filamin reduces the 
cellular tension maintained by -non-muscle actin filaments, inducing contraction of SMCs. 
 
Continuous expression of filamin mRNA in SMCs under different culture conditions  
SMCs cultured in honeycombs for 14 days immediately started to proliferate when 
they were transferred to plates (Fig. 14A), and their growth rate was almost the same as that of 
SMCs prepared from media. Filamin A mRNA expression was almost identical in SMCs 
cultured in honeycombs and on plates (Fig. 14B), and SMCs moved to plates mainly expressed 
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the 280 kDa form of filamin after 12 hours (Fig. 14C). These observations indicate that filamin 
might contribute to the phenotypic changes seen in SMCs. 
 
 
Discussion 
In this section, we focused on the regulation and role of filamin in SMCs because the 
molecular weight of filamin changed in SMCs cultured in honeycombs. Our findings indicate 
that the change in the molecular weight of filamin might be related to rearrangement of the 
cytoskeletal structure. Finally, our results suggest that SMCs cultured in honeycombs exhibit 
contraction.  
When SMCs were cultured on plates, a 180 kDa form of filamin could be produced by 
degradation of the 280 kDa form of filamin, and this degradation was almost completely 
suppressed by the calpain inhibitor ALLN (Fig. 9D). Other enzyme candidates that might also 
degrade filamin are caspase 3 and granzyme B, two key mediators of apoptosis [59, 60]; 
however, the pattern of filamin degradation produced by calpain is different from that produced 
by caspase 3 and granzyme B, and there was no indication that apoptosis was induced in SMCs 
when the 280 kDa filamin was degraded to the 180 kDa filamin. As a result, we concluded that 
the 180 kDa form of filamin was a product of degradation of the 280 kDa form of filamin by 
calpain. 
Although the degradation pattern of filamin was identical in SMCs cultured in 
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honeycombs and SMCs cultured on plates (Figs 8, 10), ALLN did not work in SMCs cultured in 
honeycombs (Fig. 9E). A possible explanation for this discrepancy is that ALLN might be 
released from cells by multidrug resistance protein (MRP)-1, which is known to transport 
ALLN, and MRP-1-overexpressing cells show distinct resistant to ALLN [61, 62]. Aorta and 
vascular SMCs have been reported to express MRP-1 abundantly [63]. On the other hand, 
incorporation activity, such as thymidine and amino acid incorporation into SMCs, was quite 
low in honeycombs [6], suggesting that SMCs cultured in honeycombs may have difficulty with 
ALLN uptake. This suggests that SMCs cultured in honeycombs might release ALLN through 
MRP-1, while barely taking up any ALLN. We therefore suggest that calpain could contribute to 
degradation of filamin in SMCs cultured in honeycombs in the current study; however, 
additional studies are needed. 
In this study, we identified a clear relationship between calpastatin expression and 
filamin degradation. Specifically, when calpastatin was expressed in SMCs, the 180 kDa form 
of filamin was absent, whereas calpastatin was not detected when the 180 kDa form of filamin 
was present. Although calpastatin is a well-known inhibitor of calpain [64], other studies have 
shown that calpastatin can be cleaved by -calpain and m-calpain in vitro when sufficient Ca2+ 
is provided [65, 66]. Despite being cleaved, calpastatin fragments were still potent inhibitors of 
calpains, though the inhibitory activity was lower [65, 66]. It has been reported that calpain 
activity is dependent on Ca
2+
-concentration [57, 67, 68]. When SMCs contract, Ca
2+
 is provided 
by Ca
2+
 influx from the extracellular space and Ca
2+
 release from the sarcoplasmic reticulum 
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into the cytoplasm [69]. Thus, it can be assumed that an increase in calpain activity induced by 
higher concentrations of Ca
2+
 might induce cleavage of calpastatin, resulting in 
calpain-mediated degradation of filamin due to the reduced inhibitory activity of the degraded 
calpastatin. 
Examination of the effects of filamin degradation on the cytoskeleton also yielded 
interesting data. It is known that degraded filamin can no longer dimerize, and the avidity of 
degraded filamin binding to actin filaments is reduced compared with that of non-degraded 
filamin [50]. Our data suggest that degradation of filamin reduces the interaction between 
filamin and -non-muscle actin filaments, which results in disruption of their co-localization 
(Fig. 11). Our data also suggest that the 280 kDa form of filamin is responsible for bundling of 
-non-muscle actin filaments in SMCs (Fig. 12). This hypothesis is supported by the 
observation that stress fibers in filamin-deficient human melanoma
 
(M2) cells were compared 
with A7 cells that were stably reconstituted
 
with filamin [70]. A7 cells spread on fibronectin and 
formed well-developed focal
 
adhesions and stress fibers, whereas filamin-deficient M2
 
cells 
attached, but remained retracted with only a few small
 
focal adhesions and rare short actin 
bundles. It has also been reported that filamin lacking a self-association domain cannot induce 
bundling of actin filaments in vitro [48]. These data suggest that degradation of filamin in SMCs 
cultured in honeycombs induces relative structural weakness of -non-muscle actin filaments 
compared with the contractile apparatus.  
Honeycombs with SMCs shrank significantly over time (Fig. 7). This shrinkage of 
46 
 
honeycombs could be the result of the tension within SMCs attached across their lumens or due 
to contraction of the SMCs. In the latter case, SMCs in honeycombs could achieve contractility 
because cellular tension maintained by -non-muscle actin filaments is reduced in these cells 
due to filamin degradation. The expression levels of -actin, MHC, tropomyosin, -actin and 
-actinin were almost identical in SMCs cultured on plates and in honeycombs, but filamin in 
SMCs cultured in honeycombs was degraded (Fig. 7E). In subconfluent SMCs cultured on 
plates, or SMCs cultured in honeycombs, - and -actin were co-localized (Fig. 13), which 
suggests that the contractile apparatus is aligned with -non-muscle actin filaments. SMCs 
cultured on plates do not contract under normal culturing conditions [71]. Our results could 
explain why contraction, which is a result of shortening of the contractile apparatus, was not 
observed in SMCs cultured on plates. SMCs attach to rigid plastic plates via focal adhesion, and 
the resulting cytoskeletal tension, which is maintained by -non-muscle actin filaments, inhibits 
shortening of the contractile apparatus. In honeycombs, SMCs can achieve contractility because 
filamin degradation reduces the cytoskeletal tension and allows shortening of the contractile 
apparatus. Features of dedifferentiated SMCs are large amounts of rough endoplasmic reticulum, 
free ribosomes and mitochondria, and proliferation in response to PDGF-BB [5, 72]. In our 
model, the number of ribosomes and mitochondria present in a certain area of SMCs cultured in 
honeycombs was almost identical with the amount of ribosomes and mitochondria in aortic 
SMCs, and the number of ribosomes and mitochondria in a single cell in honeycombs was 20% 
to 25% of that in SMCs cultured on plates. SMCs cultured in honeycombs also stopped 
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proliferating and did not respond to PDGF-BB anymore [6]. Additionally, SMCs cultured in 
honeycombs expressed caldesmon heavy chain (a marker protein of mature differentiated 
SMCs) [6, 41]. Although expression levels of -actin and MHC (a marker of differentiated 
SMCs) in SMCs cultured on plates and in honeycombs were almost identical, SMCs in 
honeycombs might be able to achieve contractility. Based on these results, we believe that 
SMCs cultured in honeycombs have the functional ability to contract. 
When SMCs were released from honeycombs and moved to plates, they immediately 
began to proliferate (Fig. 14). This response could be regarded as similar in some respects to the 
change to a proliferative phenotype of SMCs in vivo. It is assumed that SMCs can adopt a 
suitable cytoskeletal structure for their surrounding environment by rearrangement of actin 
filaments, and filamin can regulate this rearrangement. The results presented herein suggest that 
constant expression of filamin mRNA and regulation of filamin function by degradation, which 
is a post-translational regulatory mechanism, might at least partially contribute to the immediate 
and reversible phenotypic changes in SMCs. 
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Fig. 7. Changes in honeycomb size of various cultured cells. (A) Observation of honeycombs 
in a dish (diameter, 6 cm). (B) Cell growth in honeycombs. ●, SMC; ■, NIH 3T3 cell; △, 
HUVEC. (C) Changes in the area of honeycombs. The size of the honeycomb before culturing with 
cells was 6 × 6 × 2 mm. A change in the area of the honeycombs (length × width) was observed. 
○, honeycombs without cells; ●, honeycombs with SMCs; ■, honeycombs with NIH 3T3 cells; 
△, honeycombs with HUVECs. * indicates p<0.05 for the area of honeycombs cultured with a 
specific cell compared to the area of honeycombs without cells on each day. (D) Reduction of the 
area of honeycombs by one cell. Closed bar, SMC; shaded bar, NIH3T3 cell; open bar, HUVEC. 
Calculations were performed as follows: {(average of the area of honeycombs with each type of 
cells on day 0) – (the area of honeycombs with each type of cells on day 1, 3 or 7)} / the cell 
number of each type of cell on day 1, 3 or 7. *p<0.05. (E) Western blot analysis of proteins 
involved in the contractile apparatus and cytoskeleton in SMCs cultured in honeycombs for 0, 1, 3 
and 7 days.  
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Fig. 8. Change in the molecular weight of filamin in SMCs cultured under different 
conditions. Western blot analysis of filamin and related proteins. (A) Expression of 
filamin in various organs derived from Japanese white rabbits. am, aortic media; cm, 
cardiac muscle; sg, submandibular gland; p, pancreas; si, small intestine; l, liver (B) 
Honeycomb: SMCs cultured on a dish (diameter, 10 cm) were treated with 
trypsin–EDTA, and isolated cells (0 hour) were cultured in honeycombs for 6, 12, 24, and 
48 hours (hrs in figures). Plate: SMCs were plated at 5 ×10
5
 cells per dish (diameter, 10 
cm) and cultured for 3, 7 and 14 days. (C) M, aortic media of Japanese white rabbits; H, 
SMCs cultured in honeycombs for 12 hours.  
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Fig. 9. Filamin degradation. (A) Western blot analysis of filamin in SMCs. SMCs were 
plated on a dish (diameter, 10 cm) and cultured until subconfluent or confluent. (B) 
Northern blot analysis of filamin A in SMCs cultured on plates. SMCs were plated on a 
dish (diameter, 10 cm) and cultured until subconfluent or confluent. Total RNA was 
isolated, northern-blotted and probed with filamin A. (C) Western blot analysis of filamin 
in SMCs. SMCs were plated at 2 ×10
5
 cells per dish (diameter, 6 cm) and cultured for 24 
hours. Next, SMCs were incubated with 2 M ALLN (added at day 0) for 1 or 2 days. (D) 
Western blot analysis of filamin in SMCs. SMCs were plated at 2 ×10
5
 cells per dish 
(diameter, 6 cm) and cultured for 8 days to reach confluence. Two micromolar ALLN was 
then added and SMCs were incubated for 1 or 2 days. (E) Western blot analysis of filamin 
in SMCs. SMCs cultured on dishes (diameter, 10 cm) were incubated with 2 M ALLN for 
24 hours. SMCs were then treated with trypsin–EDTA, and isolated SMCs were cultured 
in honeycombs in the presence of 2 M ALLN for 1 or 2 days.  
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Fig. 10. Expression of phosphorylated filamin A and calpastatin in SMCs. Plate: SMCs 
were plated at 1.5 ×10
5
 cells per well (6-well plate) and cultured for 3, 6 and 14 days. 
Honeycomb: SMCs cultured on a dish (diameter, 10 cm) were treated with trypsin–EDTA, 
and isolated cells (day 0) were cultured in honeycombs for 1 and 2 days.  
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Fig. 11. Localization of filamin and -actin in SMCs. (A, B) SMCs were cultured to 
subconfluence on a plate. (C) Subconfluent SMCs cultured on a plate were incubated with 
0.5 M cytochalasin D for 24 hours. (D, E) SMCs were cultured in a honeycomb for 3 days. 
Green indicates filamin, and red indicates -actin. Scale bar, 20 m (A, C, D); 5 m (B, E). 
(F) Subcellular localization of filamin and -actin between cytoplasmic and cytoskeletal 
fractions in SMCs. P, SMCs cultured to subconfluence on plates; H, SMCs cultured in 
honeycombs for 3 days; whole, whole cell lysates; s, Triton X-100-soluble fraction; i, Triton 
X-100-insoluble fraction.  
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Fig. 12. Expression and localization of filamin and -actin in ODC-SMCs. The rat ODC 
gene was stably overexpressed by transfection of a pTracer-CMV plasmid encoding the rat 
ODC gene into SMCs using electroporation (ODC-SMCs). (A) Western blot analysis of 
filamin and -actin in ODC-SMCs. SMCs and ODC-SMCs were cultured on plates to 
subconfluence. Lane 1, SMC; lane 2, molecular marker; lane 3, ODC-SMC. Localization of 
filamin and -actin in SMCs (B, C) and ODC-SMCs (D, E, F). SMCs and ODC-SMCs were 
cultured on plates to subconfluence. Green indicates filamin, and red indicates -actin. Scale 
bar, 20 m (B, D, F); 5 m (C, E). 
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Fig. 13. Localization of -actin and -actin in SMCs. (A, B) SMCs were cultured on a 
plate to subconfluence. (C, D) SMCs were cultured in a honeycomb for 3 days. Green 
indicates -actin, and red indicates -actin. Scale bar, 20 m (A, C); 5 m (B, D).  
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Fig. 14. Continuous expression of filamin mRNA in SMCs under different culture 
conditions. SMCs were cultured in honeycombs for 14 days and treated with collagenase. 
Isolated SMCs were plated at 1 ×10
5
 cells per well (6-well plate) (A) Cell growth of SMCs 
cultured on plates after culturing in honeycombs for 14 days. (B) RT-PCR analysis of filamin 
A. (C) Western blot analysis of filamin.  
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Chapter 3 
Kefiran reduces atherosclerosis in rabbits fed a high-cholesterol diet  
 
Kefir is popular fermented milk in the Caucasian regions that uses kefir grains as 
starter, and many health promoting properties have been proposed [7]. Kefiran is an 
exopolysaccharide produced by Lactobacillus kefiranofaciens that is isolated from kefir grains, 
and has a repeating hexasaccharide structure with a [Glc-Gal(-Glc)-Gal-Gal-Glc]n branch. The 
molecular weight of kefiran is about 1 × 10
6
 to 4 × 10
6
 [10]. Production of kefiran by culture is 
difficult, but Maeda et. al, developed a technology for efficiently producing kefiran in a 
hydrolyzed rice medium using L. kefiranofaciens [73].  
Rice culture-derived kefiran is highly soluble in water. It has been reported to induce 
hypocholesterolemia [8, 9] and hypotensive effects like those produced by the typical 
water-soluble fibers pectin and glucomannan [74, 75]. It has been reported that: kefiran lowers 
blood cholesterol and reduces blood pressure in spontaneously hypertensive stroke-prone 
(SHRSP) rats [10, 11];
 
purified kefiran decreases blood glucose; and crude kefiran improves 
constipation [76]. Authors have shown that kefiran accelerates sterol excretion, and decreases 
histamine excretion in rats fed a high-cholesterol diet or administrated orotic acid [77]. These 
data led us to hypothesize that kefiran may promote catabolism and have anti-inflammatory 
effects.  
Kefiran is expected to ameliorate atherogenesis because kefiran has 
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hypocholesterolemic [8, 9], hypotensive [10, 11] and anti-inflammatory effects [12]. When 
rabbits were fed a high-cholesterol diet for 8–12 weeks, levels of -VLDL were elevated and a 
large area of atherosclerotic lesions developed [78, 79]. Thus, we investigated the effects of 
kefiran on atherogenesis in New Zealand White rabbits fed a 0.5% cholesterol diet.  
 
 
Materials and Methods 
Kefiran  
 “Rice kefiran” denotes a sterilized mixture of pure kefiran and L. kefiranofaciens 
bacteria cultured in rice medium [73]. Rice kefiran (Kefiran CR, Daiwa Pharmaceutical 
Company Limited. Tokyo, Japan) is a powder of dried culture filtrate containing 14% kefiran 
produced in a hydrolyzed rice medium by L. kefiranofaciens.  
 
Rabbits and food  
The care, maintenance, experimentation of animals was carried out according to the 
“Principles of Laboratory Animal Care” (NIH publication number 85–23, revised 1985) and the 
Guidelines of the Animal Investigation Committee of Chiba University (Chiba, Japan).  
Male New Zealand White rabbits (6 weeks, 1.8–2.1 kg) were obtained from Takasugi 
Experimental Animal Supply Co., Ltd. Rabbits were randomly divided into two groups. The 
control group (n=7) was fed RC (normal diet of a rabbit, Oriental Yeast Co., Ltd. Tokyo, Japan) 
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containing 0.5% cholesterol and 1% dextrin, and a kefiran-treated group (n=8) was fed RC 
containing 0.5% cholesterol and 7% rice kefiran (final concentration of kefiran, 1%). One 
percent dextrin was added to the control diet to ensure an equivalent number of calories with 1% 
kefiran [11]. These supplemented diets were prepared by Oriental Yeast Co., Ltd. Rabbits were 
fed a 100 g diet every day for 8 weeks.  
 
Preparation of -VLDL from rabbit serum 
Blood was prepared after feeding for 8 weeks. Rabbits were fasted for one day before 
blood sampling. They were anesthetized with an injection of pentobarbital (50
 
mg/kg, i.p.). Blood 
was drawn from the carotid artery, collected into sterile plastic tubes. Blood samples were 
centrifuged at 3,000 rpm in a refrigerated bench-top centrifuge for 10 minutes at 4°C. -VLDL 
(density <1.006 g/ml) was prepared from the serum of two groups of rabbits [80]. 
 
High-performance liquid chromatography (HPLC) analysis of lipoprotein profile 
   Serum samples (100 l) were obtained from all rabbits after feeding for 8 weeks. 
Levels of total cholesterol (TC), free cholesterol (FC), triglyceride (TG) and phospholipids 
(PLs) of each of the major lipoprotein classes [chylomicrons, VLDL, low-density lipoprotein 
(LDL) and high-density lipoprotein (HDL)], in the pool sera were analyzed by HPLC at 
Skylight Biotech, Incorporated (Tokyo, Japan) [81].  
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Lesion analysis 
After blood collection, aortas were perfused in situ with PBS followed by
 
4% 
paraformaldehyde. Aortas were excised and stored at 4°C.
 
After removal of connective tissue, 
aortas were opened longitudinally. Atherosclerotic lesions of the entire aorta were measured 
using a computer-based image analyzer system (Luzex 3U; Nireco, Tokyo, Japan). The aorta 
was divided into four segments as shown in Fig. 15A: the ascending aortic arch (site 1); the 
downstream region of the left subclavian artery (site 2); the aorta of the intermediate region 
between the left subclavian artery and the diaphragm (site 3); and the abdominal aorta under the 
diaphragm (site 4). The portion of each segment showing the most severe lesions shown in Fig. 
15 was removed, embedded in paraffin by a standard method, and sectioned into 6 m serial 
sections.  
 
Chemical staining and histological analyses   
Frozen sections of the aorta were stained with
 
0.1% (wt/vol) Oil Red O or Masson 
trichrome stain. The sections stained with Oil Red O were used for measurement of intimal 
lesions.  
Paraffin sections were used for immunohistochemistry. Staining using chromogen
 
diaminobenzidine (DAB) in brown was done using a Pathostain ABC-POD (M) kit (Wako Pure 
Chemical Industries, Limited, Tokyo, Japan) following the protocol provided
 
by the manufacturer. 
Monoclonal human endothelial CD31 antibody (Clone JC70A), monoclonal-smooth muscle cell
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actin antibody (Clone 1A4), and rabbit macrophage
 
marker (RAM-11) were purchased from 
Dako; monoclonal rabbit T-lymphocyte marker-CD43 antibody (Clone L11/135) was purchased 
from AbD Serotec. All primary antibodies
 
(dilution 1:100–200) were incubated overnight. Mouse 
serum (diluted 1:100) was used
 
the negative control. Slides
 
were counterstained with hematoxylin, 
blued in Scott’s tap water, dehydrated, and mounted in Di-n-butylphthalate in xylene (DPX) 
medium. 
 
Extraction of cholesterol from feces and the liver and measurement of cholesterol 
Livers were stored at –80°C until use. One hundred milligrams of each liver was 
homogenized with 1 ml of SET buffer (0.25 M sucrose, 1 mM EDTA, 50 mM Tris HCl, pH 7.4), 
and the liver samples were added 10 ml of 2:1 chloroform/methanol to extract cholesterols. 
Feces were collected from the segment of the large intestine closest to the anus, and completely 
dried in an oven set at 80°C. Dried feces (0.5 g) were crushed, added to 10 ml of 
chloroform:methanol (2:1), and mixed well. Dried feces (1.5 g) from each rabbit were used and 
the extractions mixed. The extracted chloroform solutions from the liver and feces were dried 
and dissolved in Cholesterol E-test Wako kit buffer (Wako, Tokyo). TC and FC contents were 
measured by the Cholesterol E-test Wako kit and Free Cholesterol E-test Wako kit, respectively.  
 
Determination of lipid peroxide 
Hydroperoxide content in -VLDL as lipid peroxide was determined using a 
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Determiner LPO kit (Kyowa Medex Company, Limited). 
 
Analysis of monosaccharide composition 
In order to extract saccharide from 1 ml of each sample, 1 ml of n-hexane was added 
and vortex-mixed. Preparation method and HPLC conditions for analysis of monosaccharide 
composition were described in previous report [82]. 
 
Formation of macrophage foam cells 
RAW264.7 mouse peritoneal macrophages (American Type of Cell Culture) were 
maintained in 12-well culture plates in DMEM containing 10% FBS. Cells were cultured with 
or without -VLDL (2 cholesterol mg/ml) derived from rabbits for 24 hours. Cells were fixed 
with 4% paraformaldehyde and stained with hematoxylin-eosin. Cell lipids were extracted by 
hexane:2-propanol (2:1). Lipid extracts were transferred to 96-well plates with 1% Triton 
X-100/EtOH. TC and FC contents were measured by the Cholesterol E-test Wako kit and Free 
Cholesterol E-test Wako kit, respectively.  
 
Determination of protein concentrations 
Method for determination of protein concentrations was the same as chapter 1 and 2. 
 
Statistical analysis 
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The statistical
 
significance of differences was assessed by the unpaired t-test using 
JSTAT. 
 
 
Results 
Serum cholesterol level  
There was no difference in body weight between the two groups. The initial body 
weights of control and kefiran groups were 1.95 ± 0.08 kg and 1.94 ± 0.08 kg, respectively. The 
weights at the end of the experiment were 2.64 ± 0.17 kg and 2.61 ± 0.13 kg, respectively. Table 
1 shows the levels of TC, FC, TG and PL levels in serum and lipoprotein fractions. Many values 
for the kefiran group were lower than that of control group, but statistically significant 
differences between the two groups were not observed.  
 
Reduction in the size of atherosclerotic lesions with kefiran treatment 
Lesions on the surface of the aorta were measured to clarify if kefiran intake reduced 
the size of atherosclerotic lesions (Fig. 15A). The total area of lesions in the kefiran group was 
significantly lower than those of the control group. Atherosclerotic lesions close to the heart 
(site 1) were well developed in both groups; the number of atherosclerotic lesions gradually 
decreased in aortic regions further away from the heart. Figure 15B shows Oil Red O staining of 
tissue sections from sites 1–4 in Fig. 15A. There was not a significant difference in the area of 
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atherosclerotic lesions of site 1 (which was closest to the heart) between control and kefiran 
groups. The area of atherosclerotic lesions in sites 2, 3 and 4 of the kefiran group were 
significantly decreased compared with those of the control group.  
 
Chemical staining and histological analyses   
Figure 16 shows the results of Masson trichrome staining and immunohistochemical 
analysis of the sections of sites 3 of control and kefiran groups. In the control group, the intimal 
lesion was deficient in fibrous tissue (Fig. 16A) and rich in macrophages (Fig. 16E). The inner 
layer of the intima was positive for smooth muscle cells (Fig. 16G) and was covered by 
endothelial cells (Fig. 16C). T-lymphocytes were also detected in the sections of site 3 (Fig. 16I) 
and site 4 (data not shown), but were not detected in site 1 and site 2 (data not shown). The 
sections of site 3 in control groups showed typical pathology for atherosclerosis. Site 3 of the 
kefiran group showed very small atherosclerotic lesions that may be the initial stage of the 
lesion process. The small atherosclerotic lesion was positive for macrophages and 
T-lymphocytes (Fig. 16F and J), but positive staining for T-lymphocytes was not detected in all 
other sections in kefiran groups (data not shown). We hypothesize that these inflammatory 
events may be strongly suppressed in the kefiran group, and that kefiran may prevent the onset 
and/or development of atherosclerosis.  
 
Cholesterol content in stools and the liver  
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FC contents in stools were measured to clarify if kefiran prevents absorption of FC in 
food from the intestine (Fig. 17A). There was no difference between control and kefiran groups, 
suggesting that kefiran did not influence the absorption of cholesterol from chow.  
Next, cholesterol contents in the liver were measured to assess the effect of kefiran 
on cholesterol metabolism in this organ (Fig. 17B). Levels of TC, FC and cholesteryl ester of 
the liver in the kefiran group were significantly reduced compared with those in the control 
group, suggesting that cholesterol catabolism may be promoted in the kefiran group.  
 
Presence of galactose and lipid peroxide 
It is not known if kefiran is taken into cells. The mechanism of how kefiran 
suppresses atherosclerosis in rabbits is also unknown. Levels of glucose and galactose were 
measured in serum because kefiran is composed of these compounds (Table 2). Glucose levels 
in the serum of control and kefiran groups were identical. Galactose was not detected in the 
serum of either group. Levels of glucose and galactose in -VLDL derived from the kefiran 
group were significantly higher than those of the control group. This suggests that kefiran may 
be taken up by cells and concentrated into -VLDL in the kefiran group. It was expected that 
kefiran may influence -VLDL, so the degree of oxidation of the latter was measured (Table 2). 
The level of lipid peroxide of-VLDL in the kefiran group was only about 18% of that of the 
control group.  
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Effect of -VLDL prepared from the kefiran group on RAW264.7 macrophages 
The lipid peroxide level of -VLDL prepared from the kefiran group was quite low, 
so the effect of -VLDL from both groups on RAW264.7 macrophages was investigated. Cell 
morphology was changed after RAW264.7 macrophages were treated with -VLDL (Fig. 18A); 
RAW264.7 macrophages incubated with -VLDL from the control group show a spindle shape. 
Cells showed a spherical shape when RAW264.7 macrophages were treated with -VLDL from 
the kefiran group. TC, FC and cholesteryl ester content in RAW264.7 macrophages treated with 
-VLDL from the kefiran group were significantly lower than those in cells incubated with 
-VLDL from the control group (Fig. 18B).  
 
 
Discussion 
Kefiran intake greatly reduced the size of atherosclerotic lesions in cholesterol-fed 
rabbits. It has been believed that water-soluble dietary fiber is not absorbed and has a unique 
physiological function in the intestine [77]. Our results suggest that kefiran (or its components) 
was absorbed into the blood and may influence atherogenesis because galactose was present in 
-VLDL.  
Intact kefiran in -VLDL was not detected by enzyme-linked immunosorbent assay, 
(ELISA); (ELISA can detect intact kefiran) (data not shown). This indicates that kefiran had 
been digested in the body and converted to oligosaccharide. Glucose and galactose contents in 
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-VLDL were significantly increased in the kefiran group, but serum glucose was similar in the 
two groups and serum galactose was not detected in either group (Table 2). The major pathway 
for galactose metabolism is considered to be the conversion of galactose to glucose by Gal-1-P, 
UDP-gal, and glucose-1-P. This conversion of galactose to glucose can be enhanced by glucose 
via an increase in the activity of galactose-1-phosphate uridyltransferase (GALT) in the liver 
and also via the action of insulin [83]. If there is a block in either step, galactosemia occurs, 
which can cause disorders such as ovarian dysfunction or cirrhosis [84]. If galactose is present 
as a monosaccharide in -VLDL and the liver, galactose should be converted to glucose by 
GALT. Galactose was probably present as an oligosaccharide because serum galactose was not 
detected. These findings suggest that kefiran may be digested to an oligosaccharide, and that the 
oligosaccharide may be present in -VLDL. -VLDL is released from the liver, so -VLDL 
including the oligosaccharide derived from kefiran may be present in the liver.  
It has been reported that kefiran lowers blood cholesterol in SHRSP rats [10, 11]. In 
this report, mean TC level was statistically decreased to 90.9% in SHRSP rats given 0.3 g 
kefiran/kg by gastric intubation with high fat diet compared to control group. In our study, mean 
TC levels in serum and -VLDL, from rabbits fed about 0.5 g kefiran/kg in a 0.5% cholesterol 
diet were decreased to 84.5% and 80.2%, respectively, compared to control group (Table 1). 
Although there were no statistically significant differences between the two groups because of 
relative large standard deviations, it is expected that kefiran intake may decrease the serum lipid 
levels in rabbits.  
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Atherogenesis is an inflammatory process accompanied by recruitment and 
activation of immune cells such as T-lymphocytes [85, 86]. The effects of oligosaccharides on 
inflammation have been reported; acidic oligosaccharides derived from human milk and from 
plants influence production of interleukin (IL)-4 and IL-13, and activation of T-cells derived 
from cord blood in vitro [87]; human milk and schistosome oligosaccharides secrete 
anti-inflammatory cytokines that suppress T-helper type cells and the inflammatory response 
[88]. Intragastric administration of kefiran prevented ovalbumin-induced lung inflammation in a 
murine model of asthma [12]. In our model, detection of T-lymphocytes was very low in the 
kefiran group, and the area of macrophage-positive atherosclerotic lesions in the kefiran group 
was reduced compared with those of control groups. Kefiran may inhibit lymphocyte activation. 
If so, this may explain why atherosclerotic lesions were strongly suppressed in site 3 and site 4 
in Fig. 15, but lesions were not suppressed in site 1. Site 1, which was close to the heart, may 
have been strongly influenced by blood pressure. There was no difference in blood pressure 
between control and kefiran groups (data not shown), so the activation level of endothelial cells 
in site 1 may have been almost identical in both groups. Site 3 and site 4 may have been 
dependent on the activation level of T-lymphocytes to induce atherogenesis because these areas 
were far from the heart. The areas of atherosclerotic lesions in rabbits of the kefiran group were 
reduced if activation level and cell number of lymphocytes was decreased by kefiran intake.   
Macrophages take up -VLDL including oligosaccharide derived from kefiran, 
resulting in a change in shape of macrophages. This suggests that oligosaccharide may change 
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cell characteristics. Macrophages from human monocytes in FBS with 
macrophage-colony-stimulating factor (M-CSF) showed a spindle shape and constitutive 
fluid-phase uptake of native LDL, leading to formation of foam cells [89]. Macrophages 
differentiated with granulocyte-macrophage (GM)-CSF macrophages, maintained a spherical 
shape, and accumulated cholesterol lower than M-CSF-treated macrophages when macrophages 
were incubated with 2 mg/ml LDL for 24 hours [90]. These data are quite similar to our data 
(Fig. 18). Macrophages treated with M-CSF or GM-CSF showed different gene-expression 
patterns [90], so it was expected that the pattern of gene and protein expression was changed in 
RAW264.7 macrophages treated with -VLDL from the kefiran group. These results suggest 
that exogenous oligosaccharide may have an effect on cellular function.  
Milk-kefir and soymilk-kefir displayed a great scavenging activity upon 
1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals, an inhibition effect upon linoleic acid 
peroxidation, and a substantial reducing power [91]. It has been reported that wheat bran 
feruloyl oligosaccharides significantly increased total antioxidant capacity (TAOC) level, and 
the activities of glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD), but 
decreased levels of blood glucose and malondialdehyde (MDA) and xanthine oxidase (XOD) 
activity in the serum and liver of diabetic rats compared with diabetic controls. Feruloyl 
oligosaccharides also showed greater antioxidant capacity in vivo than in vitro when compared 
with vitamin C [92]. From these findings, it is expected that the greatly lower level of oxidation 
in -VLDL from the kefiran group may depend on oligosaccharide derived from kefiran 
69 
 
reducing oxidation in serum and the liver. Oxidative lipoproteins induce the formation of foam 
cells [93-100], so macrophages treated with -VLDL from the kefiran group accumulated less 
cholesterol and reduced the area of atherosclerotic lesions in the kefiran group.  
The reason why kefiran intake reduced the area of atherosclerotic lesions in our 
experiments may be explained by three possibilities: (i) suppression of inflammation in the 
kefiran group, (ii) less accumulation of cholesterol in macrophages of the kefiran group, and 
(iii) lower serum lipid levels in the kefiran group. Another issue is the change in cholesterol 
metabolism in the liver. Oligosaccharide derived from kefiran is assumed to be present in 
-VLDL, so oligosaccharides were already allowed into hepatocytes after kefiran intake. The 
oligosaccharide may then influence the reduction of cholesterol content in the liver, but the 
mechanism is not known. The pathway by which kefiran reaches the liver is also not known: 
was kefiran absorbed intact or were its decomposition products absorbed after intestinal 
digestion? Although radioactive kefiran by oral administration is known to distribute in organs 
such as liver, kidney urinary bladder etc. [101], whether kefiran enters cells lining the intestine, 
macrophages, or dendritic cells is also not known. The monocyte/macrophage cell lines U937 
and J774.1 cells bind and internalize water-soluble pharmaceutical grade (1–3)-beta-D-glucan 
phosphate [102]. Dendritic cell-specific intercellular adhesion
 
molecule-grabbing non-integrin 
(SIGN)-R1 transfected cells take up mannose conjugates and dextran conjugates [103].
 
Macrophages could possibly take up a large molecule in sugar chains.  
Kefiran intake decreased the size of atherosclerotic lesions in hypercholesterolemic 
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rabbits and did not show adverse effects in these animals. Our findings show that kefiran is a 
healthy food that may inhibit atherogenesis.  
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Table 1   Lipid concentrations in the serum 
 
 cholesterol (mg/dl) 
total CM VLDL LDL HDL 
control 2488.7 ± 497.9  6.8 ± 3.1 1942.4 ± 448.8 468.3 ± 47.9 70.7 ± 11.6 
kefiran 2103.0 ± 642.0 10.2 ± 4.7 1557.8 ± 496.7 460.4 ± 154.5 74.5 ± 15.0 
 free cholesterol (mg/dl) 
total CM VLDL LDL HDL 
control 591.4 ± 106.4 0.8 ± 0.2 446.2 ± 92.1 132.4 ± 16.4 12.0 ± 2.0 
kefiran 469.1 ± 153.0 1.0 ± 0.4 337.1 ± 113.7 118.6 ± 40.9 12.4 ± 2.7 
 triglyceride (mg/dl) 
 total CM VLDL LDL HDL 
control 85.7 ± 68.1 0.5 ± 0.3 64.7 ± 52.3 15.6 ± 12.1 5.0 ± 3.6 
kefiran 52.4 ± 31.2 0.4 ± 0.2 37.1 ± 23.0 10.7 ± 5.8 4.2 ± 2.9 
 phospholipids (mg/dl) 
 total CM VLDL LDL HDL 
control 846.1 ± 149.2 1.4 ± 0.4 618.0 ± 117.9 189.8 ± 29.9 37.0 ± 11.0 
kefiran 699.9 ± 213.9 1.7 ± 0.8 483.0 ± 156.5 177.2 ± 58.8 38.0 ± 9.6 
Measurement of lipid levels is described in Method. The data are shown the mean ± SD. 
 
72 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
 
 
  
   
Fig .15. Effect of kefiran on the surface area of atherosclerotic lesions of the aortic arch (A) 
and Oil Red O staining of cross-sections (B).  Rabbits were fed a 0.5% cholesterol diet 
(control) and a 0.5% cholesterol plus kefiran diet (kefiran). Measurement of surface area (A) and 
intimal lesion (B), and calculation of the percentage of atherosclerotic lesions in each table are 
described in the “Materials and methods” section. Values are mean ± SD. *p<0.05, **p<0.01.  
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Fig. 16. Masson trichrome staining and immunohistochemistry of cross-sections 
of the aorta. Cross-sections were prepared from site 3 of the aortas of control and 
kefiran groups. Panels A and B, Masson trichrome staining; panels C and D, 
immunostaining using anti-endothelial CD31 antibody (JC70A); panels E and F, 
immunostaining using anti-macrophage antibody (RAM11); panels G and H, 
immunostaining using anti-smooth muscle actin antibody (1A4); panels I and J, 
immunostaining using monoclonal rabbit T-lymphocyte marker-CD43 antibody (Clone 
L11/135). Panels A, C, E, G and I were sections from the control group and panels B, 
D, F, H and J were from the kefiran group. The scale bar denotes 200 m in each 
photograph. Brown area is positive immunostaining and blue area is nuclear staining 
produced with hematoxylin.  
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Fig .17. Cholesterol contents in stool (A) and the liver (B). Extraction of cholesterol 
and measurement of total cholesterol and free cholesterol are described in the “Materials 
and methods” section. Samples derived from the control group show control; samples 
derived from the kefiran group show kefiran. TC, total cholesterol content; FC,free 
cholesterol content; CE, cholesteryl ester content. Values are mean ± SD. *p<0.05, 
**p<0.01.  
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Fig. 18. Difference in RAW264.7 macrophage accumulation for -VLDL prepared 
from control and kefiran groups. (A) Changes in morphology of RAW264.7 
macrophages incubated with or without 2 mg total cholesterol/ml -VLDL prepared from 
control and kefiran groups for 24 hours. Cells were stained by hematoxylin-eosin 
staining. “Non-treated” represents cells incubated without -VLDL. Bar denotes 50 m in 
each photograph. (B) Cholesterol content in RAW264.7 macrophages after incubation 
with -VLDL. RAW264.7 macrophages (0.8 ×10
5
 cells/well, 12-well plate) were incubated 
for 24 hours with or without -VLDL (2 mg total cholesterol/ml) prepared from control and 
kefiran groups. Extraction and measurement of cholesterol are as described in the 
“Materials and methods” section. “Non-treated” represents cells incubated without 
-VLDL. Values are mean ± SE of triplicate determinations. *p<0.05, **p<0.01. 
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Summary 
1. Relationship between eukaryotic initiation factors and proliferative arrest of vascular 
smooth muscle cells cultured in type-I collagen matrix honeycombs 
We mainly used human SMCs (derived from a 36 year-old man) for experiments. The 
SMC cell number cultured in honeycombs did not change, whereas the SMC proliferated 
rapidly on plates. Incorporation of [
3
H]leucine in SMCs cultured in honeycombs for 24 hours 
was lower than that in SMCs cultured on plates, suggesting that a decrease in protein synthesis 
may be responsible for growth inhibition in honeycombs.  
We focused on eukaryotic initiation factors (eIFs), which together with RNA 
molecules regulate translation initiation. It is known that phosphorylation of eIF2 inhibits 
protein synthesis. eIF2 phosphorylation was increased in SMCs within 6 hours after culturing 
in honeycombs. It has been reported that depletion of intracellular polyamines induces eIF2 
phosphorylation. Intracellular spermine (one of the major polyamines) content was decreased in 
SMCs cultured in honeycombs for 6 hours. When inhibitors of ornithine decarboxylase (ODC) 
and S-adenosylmethionine decarboxylase (SAMDC), which are rate-limiting enzymes for 
polyamine synthesis, were added to SMCs cultured on plates, intracellular spermine was 
decreased, and eIF2 phosphorylation was increased. This data suggests that spermine content 
may be one of the important factors for regulating phosphorylation of eIF2in SMCs cultured 
in honeycombs.       
   Among eIFs, protein expressions of eIF4B (a helicase-stimulatory factor) and eIF4G 
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(a large scaffold protein) were dramatically decreased in SMCs cultured in honeycombs. mRNA 
levels of eIF4B and 4G in SMCs cultured in honeycombs were almost the same as those in 
SMCs cultured on plates, indicating that either translation of eIF4B and 4G were limited, or 
degradation of these eIFs was promoted. To determine the effects of polyamine on translation of 
eIF4B, a fusion gene containing the 5’-untranslated region and 99 bp of the open reading flame 
of the eIF4B gene fused to the EGFP gene was transiently transfected into rabbit SMCs cultured 
on plates. When intracellular spermine content was decreased by inhibitors of ODC and 
SAMDC, both mRNA and protein levels of EGFP did not change. However, when spermine 
content was decreased, protein expression of eIF4B-EGFP was decreased although mRNA 
levels did not change, indicating that synthesis of eIF4B was regulated by polyamines at the 
level of translation. This suggests that a decrease in spermine level might induce translational 
inhibition of eIF4B in SMCs cultured in honeycombs. Next, we examined whether degradation 
of eIF4B and 4G were promoted in honeycombs. SMCs were cultured with cycloheximide on 
plates to evaluate the half-life of eIF4B and 4G. The half-life of both eIF4B and 4G was longer 
than 24 hours. However, expressions of eIF4B and 4G decreased within 6 hours of SMCs being 
cultured in honeycombs, indicating that degradation of eIF4B and 4G were promoted in SMCs 
cultured in honeycombs.  
From these results, we propose that regulation of eIFs (phosphorylation, translation 
and degradation) decreases protein synthesis, inducing proliferative inhibition of SMCs cultured 
in honeycombs. 
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2. Degradation of filamin induces contraction of vascular smooth muscle cells in type-I 
collagen matrix honeycombs 
We used SMCs derived by the explant method from aortic media of Japanese white 
rabbits for experiments. Changes in the size of the honeycombs used for culturing SMCs and 
other non-contractile cells (NIH3T3 cells and human umbilical vein endothelial cells) were 
investigated to determine whether SMCs cultured in honeycombs can contract. The area of the 
honeycombs was reduced after culturing each cell-type. Moreover, the honeycomb areas of 
SMC cultures were reduced to a greater extent than the honeycomb areas of the other two 
cell-types. This suggests that SMCs that attach across the lumen of the honeycombs have 
contractile activity. Among expression of proteins involved in both the contractile apparatus and 
the cytoskeleton of SMCs cultured in honeycombs, that of filamin, which is an actin-binding 
protein, was changed. SMCs at day 0 expressed the 280 kDa form of filamin, while SMCs 
cultured in honeycombs expressed the 280 and 180 kDa forms of filamin. We hypothesized that 
there might be some relationship between changes in the molecular weight of filamin and 
contraction of SMCs in honeycombs. 
Full-length 280 kDa filamin was expressed in subconfluent SMCs cultured on plates; 
however, the 280 and 180 kDa forms of filamin were observed in confluent SMCs cultured on 
plates and in honeycombs. By treatment with calpain inhibitor, the change in the molecular 
weight of filamin was inhibited in SMCs cultured on plates. We suggest that filamin was 
degraded by calpain in confluent SMCs cultured on plates and those cultured in honeycombs to 
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generate the 180 kDa form of filamin. This might be regulated by expression of calpastatin, an 
endogenous inhibitor of calpain.  
   To clarify the intracellular distribution of filamin after degradation, we examined 
filamin and -actin expression by immunofluorescence microscopy. Filamin was observed 
along fibers and co-localized with -actin in subconfluent SMCs cultured on plates. When 
incubated with cytochalasin D, this co-localization was disrupted, suggesting that filamin 
interacts with -non-muscle actin filaments. In honeycombs, filamin staining was evenly 
detected in the cytoplasm and was not stained as fibers in most cells. When Triton 
X-100-soluble (cytoplasmic) and -insoluble
 
(cytoskeletal) fractions were prepared, degraded 
filamin (i.e., 180 kDa filamin) was mainly detected in the cytoplasmic fraction of these cells. It 
can be assumed that degraded filamin, which does not bind to -non-muscle actin filaments, 
was present in the cytoplasmic fraction in SMCs cultured in honeycombs.  
   To confirm the function of full-length filamin in SMCs, we observed -non-muscle 
actin filaments in SMCs overexpressing ODC (termed ‘ODC-SMCs’). Expression of filamin 
was dramatically decreased in ODC-SMCs compared to SMCs. In ODC-SMCs cultured on 
plates, -non-muscle actin filaments were thinner than those of SMCs, although expression of 
-actin, as detected by Western blot analysis, was similar in SMCs and ODC-SMCs. This 
suggests that the full-length filamin was responsible for bundling of -non-muscle actin 
filaments in SMCs. These data suggest that degradation of filamin in SMCs cultured in 
honeycombs induces relative structural weakness of -non-muscle actin filaments.  
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Our results suggest that degradation of filamin reduces the cellular tension maintained 
by -non-muscle actin filaments, inducing contraction of SMCs. 
 
3. Kefiran reduces atherosclerosis in rabbits fed a high-cholesterol diet 
We investigated the antiatherogenic effect of kefiran in rabbits fed a high-cholesterol 
diet. Male New Zealand White rabbits were fed a 0.5% cholesterol diet without (control group, 
n=7) or with kefiran (kefiran group, n=8) for eight weeks. Cholesterol, triglyceride and 
phospholipid levels of serum and lipoprotein fractions were not significantly different between 
these groups. Aortic atherosclerotic lesions in the kefiran group were significantly less than 
those lesions of the control group. T-lymphocytes were not detectable in the aorta of the kefiran 
group. This suggests that inflammatory events may be strongly suppressed in the kefiran group. 
Cholesterol contents in stools were almost identical in both groups, suggesting that kefiran did 
not influence the absorption of cholesterol from chow. Cholesterol content in the liver of the 
kefiran group animals was significantly lower than that of the control group. Galactose content 
of -VLDL isolated from kefiran group animals was higher, suggesting that kefiran may be 
taken up by cells and concentrated in -VLDL in the kefiran group. It was expected that kefiran 
may influence -VLDL, so the degree of oxidation of-VLDL was measured. The lipid 
peroxidation level of -VLDL in the kefiran group was much lower than that in the control 
group. Then, the effect of -VLDL from both groups on RAW264.7 macrophage cholesterol 
accumulation was investigated. RAW264.7 macrophages treated with -VLDL from the kefiran 
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group showed a more spherical shape and accumulated significantly less cholesterol compared 
with macrophages treated with -VLDL from the control group. From these results, we propose 
that oral-derived kefiran is absorbed in the blood and prevents the development of 
atherosclerosis in hypercholesterolemic rabbits by anti-inflammatory and anti-oxidant actions. 
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Conclusion  
We investigated the mechanisms of phenotypic changes in SMCs cultured in type-I 
collagen matrix honeycombs. We focused on proliferative inhibition and induction of 
contraction of SMCs cultured in honeycombs. In the first chapter, we investigated the regulation 
of eukaryotic initiation factors (eIFs). We propose that regulation of eIFs (phosphorylation, 
translation and degradation) decreases protein synthesis, inducing proliferative inhibition of 
SMCs cultured in honeycombs. In the second chapter, we focused on the regulation and 
function of filamin. Our findings indicate that the change in the molecular weight of filamin 
might be related to rearrangement of the cytoskeletal structure. Finally, our results suggest that 
SMCs cultured in honeycombs exhibit contraction.  
Research for prevention and clinical treatment of atherosclerosis is quite important as 
well as understanding of the cellular biology involved in atherosclerosis. We focused on 
components of food for preventing atherogenesis. In chapter 3, we investigated the 
antiatherogenic effect of kefiran. Kefiran prevents the development of atherosclerosis in 
hypercholesterolemic rabbits by anti-inflammatory and anti-oxidant actions. 
It is expected that these results presented herein could encourage the research and 
clinical treatment of atherosclerosis. 
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